Implications of Genetic Variation, Evolution, and Heterogenicity of PRRSV in the Development of a PRRSV Universal Vaccine

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Animal Genetics and Genomics".

Deadline for manuscript submissions: closed (1 April 2020) | Viewed by 204

Special Issue Editor


E-Mail Website
Guest Editor
Veterinary Diagnostic Laboratory, Department of Veterinary Diagnostic & Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA
Interests: swine infectious diseases; porcine circoviruses; senevacirus; porcine epidemic diarrhea virus

Special Issue Information

Dear Colleagues,

Porcine respiratory and reproductive virus is still one of the most threating diseases that affects commercial swine worldwide. PRSSV infection causes reproductive failure and respiratory disease in grower-finisher pigs that lead to significant economic losses. The impact of PRRSV has become even more significant with the emergence of high pathogenic strains. Advances in transcriptomic, genomic, vaccinology, and adjuvant technology have provided new tools for the control and prevention of the disease. However, currently there is no vaccine that can successfully protect and prevent clinical presentation. The rapid evolution and genetic variability of PRRS virus are perhaps the main reasons that have impaired serious advances in the development of a universal vaccine that can protect swine population against a wide range of field strains. This Special Issue on the genetic variation, evolution, and heterogenicity of PRRSV aims to provide a critical review from authorities in the field on recent advances in PRRSV genetic, evolution, and its application toward the development of new vaccines technologies that help to mitigate and prevent the impact of PRRSV infection.

Prof. Pablo Pineyro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • PRRSV
  • Genomic
  • Evolution
  • Trascriptomic
  • Vaccinology
  • Prevention

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop